Driving Innovation in Portable Genomic Analysis with InChroSil Technology
Our Story
ICS Genomics was founded in 2025 by Jose Daniel Llopis to commercialize his family's pioneering technology. As one of the original inventors of InChroSil alongside his siblings, Jose has spent nearly two decades developing and modernizing their breakthrough invention. Recognizing the critical gap between explosive genetic data growth and limited computational infrastructure, Jose decided to bring their family's innovation to market.
Origins of our core technology. Inchrosil — Inorganic Chromosome Based in Silicon — was originally conceived and patented by the Llopis siblings under Threellop Nanotechnology Inc. as a radically new way to emulate DNA behaviour inside electronic circuits.
ICSDNA EdgeGen
ICSDNA EdgeGen is an advanced product that revolutionizes the way workflows are automated, particularly in the realm of genomic analysis. By utilizing cutting-edge analytics, ICSDNA Edgen efficiently manages and streamlines complex processes that are essential in the medical and research fields. The integration of distributed computing plays a significant role in this technology, enabling the system to handle vast amounts of data concurrently.